News & Events

CiceroDx announces launch of ReceptivaDx for Unexplained Infertility & Detection of Endometriosis

February 2018 – ReceptivaDx™ Test Now Being Used by over 150 IVF Centers Nationwide; CiceroDx, Inc. Adds Second US Laboratory Site to Meet Demand

November 14, 2017 – BusinessWire.com – BCL6 Biomarker Predicts IVF Success and Failure in Pivotal Study

June 6, 2017 – ‘Breakthrough’ Test for Unexplained Infertility Now Available

February 2019 – New Clinical Study Further Validates Use of ReceptivaDx™ (BCL6) Testing for Women with Unexplained Infertility by Demonstrating Successful Treatment Outcomes, Improved Live Birth Rates and Reduced Miscarriage Rates

December 2017 – 2017: A Progress Report

December 2017 – What is Endometriosis?

October 2017 – WWFM: Stealth endo conquered by IVF+ICSI, PGS, ERAx3, ReceptivaDX, Depot Lupron, Intralipid

June 9, 2017 – SheKnows.com – The Breakthrough Option for Treating Unexplained Infertility

March 9, 2019 – Gateway to Parenthood – Ameristar Resort & Casino, St. Louis Metro Area, MO – http://www.mcrmfertility.com/gateway-to-parenthood

April 3 – 7, 2019 – Pacific Coast Reproductive Society – Indian Wells, CA – http://www.pcrsonline.org

June 5 – 8, 2019 – Midwest Reproductive Symposium International – Chicago, IL – http://www.midwestreproductivesymposium.com

October 12 – 16, 2019 – CiceroDx to exhibit at American Society of Reproductive Medicine (ASRM) – Philadelphia, PA – https://www.asrm.org/events/2019-scientific-congress-and-expo